Status:
COMPLETED
Immediate Effect of Proponent-Nasal-Spray on Unspecific Discomfort in the Nose
Lead Sponsor:
PRECLIN Biosystems AG
Conditions:
Unspecified Disorder of Nose and Nasal Sinuses
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Investigation of the immediate effect on subjective relief of symptoms by Proponent - Nasal - Spray after a one time administration (following a single dose administration in each nostril) in an open,...
Detailed Description
By regularisation of environment of nasal mucosa and the following restitution and improvement of the ciliary function the efficacy of mucociliary clearance can be remarkably enhanced, pathogens from ...
Eligibility Criteria
Inclusion
- Key inclusion criteria are one or more of the following symptoms:
- nasal discharge/ secretion (runny nose)
- congested nose
- sneezing
- itchy nose
- feeling of a dry nose
Exclusion
- Key exclusion criteria:
- \<18 years of age
- 75 years of age
Key Trial Info
Start Date :
April 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2017
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03251066
Start Date
April 27 2017
End Date
June 30 2017
Last Update
August 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Ohren-, Nasen-, Hals- und Gesichtschirurgie University Zürich
Zurich, Canton of Zurich, Switzerland, 8091